Skip to content
Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan.
Konnai K, Fujiwara H, Kitagawa M, Wakabayashi R, Yumori A, Notomi T, Onose R, Kato H, Narimatsu H.
Arch Public Health. 2023 Feb 27;81(1):32. doi: 10.1186/s13690-023-01048-9.
A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: a case report.
Colombo M, Mondini P, Minenza E, Foglia C, Mosconi A, Molica C, Pistola L, Ludovini V, Radice P.
Front Oncol. 2023 Feb 27;13:1102184. doi: 10.3389/fonc.2023.1102184.
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
Emiroglu S, Özkurt E, Cabioglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M, Tukenmez M.
Breast Cancer (Dove Med Press). 2023 Feb 21;15:163-173. doi: 10.2147/BCTT.S395054.
A Highly Conserved Region in BRCA2 Suppresses the RAD51-Interaction Activity of BRC Repeats.
Zhu Z, Kitano T, Morimatsu M, Ochiai K, Ishiguro-Oonuma T, Oosumi K, Lin X, Orino K, Yoshikawa Y.
Vet Sci. 2023 Feb 10;10(2):145. doi: 10.3390/vetsci10020145.
Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand.
Sukpan P, Kanokwiroon K, Sriplung H, Laochareonsuk W, Choochuen P, Auseng N, Wanawanakorn K, Sangkhathat S.
Asian Pac J Cancer Prev. 2023 Feb 1;24(2):525-530. doi: 10.31557/APJCP.2023.24.2.525.
Post navigation